Skip to main content
Move the World.
psilocybe cubensis beer yeast

Research into the therapeutic potential of psilocybin mushrooms, like Psilocybe cubensis, is hitting the mainstream. The center of gravity for psilocybin has shifted from hippie communes and people with clay fungus charms to prestigious scientists and institutions like Johns Hopkins.

But guaranteeing the quality and consistency of the magic mushroom drug — a crucial step for real scientific research — has been a challenge.

Now, the Danish synthetic biology company Octarine is creating the psilocybin molecule that researchers need using another familiar drug friend: Saccharomyces cerevisiae — a beer yeast.

Making a Psilocybin Molecule

Bio-based production of psilocybin has already been done in E.coli bacteria. According to Octarine's press release, the method has some issues, though. An enzyme that is key to producing the psilocybin molecule is missing in the bacteria. Fixing the issue is expensive, making the process too costly to do on a large scale.

Octarine's technique uses our beer buddies to create the psilocybin molecule found in Psilocybe cubensis — the bone-white psilocybin mushrooms with the toasted-marshmallow colored caps, familiar to folks in the know.

Beer yeast has a long history of commercial use; combine that with its close relation to Psilocybe cubensis, and it’s a promising way to create psilocybin at scale.

The genetic material that Psilocybe cubensis uses to create the psilocybin molecule is optimized to be expressed in the beer yeast and then inserted into the yeast's genome, Octarine co-founder and chief science officer Nick Milne told Technology Networks.

An amino acid called tryptophan — most famous for Thanksgiving dinner — is also an important part of the process, so the beer yeast is additionally modified to produce more of it than usual.

"This is actually a really important aspect of metabolic engineering," says Milne. "(T)hese days it's usually relatively straightforward to engineer an organism to produce a foreign molecule, but getting the organism to produce enough of the molecule to be commercially relevant is a key challenge in the field."

While chemical synthesis is useful for creating some compounds, others, like the psilocybin molecule, have a complex chemistry ill-suited to the technique. This makes the psilocybin molecule difficult to synthesize cost effectively.

Beer yeast has a long history of commercial use; combine that with its close relation to Psilocybe cubensis, and it's a promising way to create psilocybin at scale.

There's still a big challenge, Octarine admits in its press release. A group of amino acids on the psilocybin molecule is getting cleaved in the process. "Essentially, we are losing half of our product because the phosphate (amino acid) group falls off," Milne said, so more metabolic engineering will be needed to solve the problem.

Research into psilocybin therapy for depression, addiction, and other mental health disorders has been in something of a renaissance recently, and mastering synthesis of it would be a big help.

As the psilocybin molecule continues its path from illegal drug to legal medication, processes like Octarine's beer yeast method may help it along the way — after all, you gotta have a good hook up.

We'd love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected]

Up Next

Catalysts
This Woman is On a Mission to Turn Beer into Food
This Woman is On a Mission to Turn Beer into Food
Catalysts
This Woman is On a Mission to Turn Beer into Food
Jacquie Berglund is using the profits from her beer company to buy organic produce from local farmers and distribute the produce to food banks in the area.

Jacquie Berglund considers herself more of a wine drinker than a beer drinker, yet she is building an empire around the beer brand, Finnegans. When Berglund purchased the brand for only a dollar, she knew that if Finnegans were to make an impact, the beer needed to be in every pub in Minnesota. Now you can find Finnegans in four Midwest states. But Finnegans is more than a beer company. From combating food insecurity to...

Dope Science
Psychedelic Mushrooms Explained
Psychedelic Mushrooms Explained
Dope Science
Psychedelic Mushrooms Explained
Psychedelic mushrooms, AKA magic mushrooms or psilocybin mushrooms, are currently being researched as a treatment for depression, addiction, and more.

Psychedelic mushrooms, AKA magic mushrooms or psilocybin mushrooms, are currently being researched as a treatment for depression, addiction, and more.

Dope Science
Microdosing Psychedelics
microdosing psychedelics
Watch Now
Dope Science
Microdosing Psychedelics
Microdosing is the no-flowers-in-your-hair practice of regularly taking minimal amounts of hallucinogenic substances. Although it’s currently illegal, millions of dollars are being poured into further research.
Watch Now

Microdosing is the no-flowers-in-your-hair practice of regularly taking minimal amounts of hallucinogenic substances. Although it’s currently illegal, millions of dollars are being poured into further research.

Dope Science
“Candy Flipping” — Mixing MDMA and LSD — Is Hitting the Lab
candy-flipping
Dope Science
“Candy Flipping” — Mixing MDMA and LSD — Is Hitting the Lab
A clinical trial of mixing LSD and MDMA, known as “candy flipping,” wants to see if molly can take a trip’s edge off and make LSD therapy more effective.

A clinical trial of mixing LSD and MDMA, known as “candy flipping,” wants to see if molly can take a trip’s edge off and make LSD therapy more effective.

Dope Science
Microdosing LSD May Provide Pain Relief
microdosing lsd
Dope Science
Microdosing LSD May Provide Pain Relief
Since the 1960s, LSD has been seen as a potential painkiller. Now, new research suggests microdosing LSD may indeed provide relief.

Since the 1960s, LSD has been seen as a potential painkiller. Now, new research suggests microdosing LSD may indeed provide relief.

Dope Science
Psilocybin May Impact Your Ego Center
psilocybin
Dope Science
Psilocybin May Impact Your Ego Center
You’ve heard about “ego death” on magic mushrooms. New research suggests psilocybin curbs part of the brain that may tie in to ego.

You’ve heard about “ego death” on magic mushrooms. New research suggests psilocybin curbs part of the brain that may tie in to ego.

Dope Science
An LSD Trip “Off-Switch” May Be Coming Soon
LSD Trip
Dope Science
An LSD Trip “Off-Switch” May Be Coming Soon
Pharmaceutical startup MindMed is developing tech it believes could serve as an “off switch” for an LSD trip during therapy sessions.

Pharmaceutical startup MindMed is developing tech it believes could serve as an “off switch” for an LSD trip during therapy sessions.

Dope Science
Could VR Change How You Trip on Ketamine?
ketamine and virtual reality
Dope Science
Could VR Change How You Trip on Ketamine?
Virtual reality meets ketamine therapy to help treat pain, anxiety, and depression, to name a few.
By Sarah Wells

Virtual reality meets ketamine therapy to help treat pain, anxiety, and depression, to name a few.